Central Alerting System
View Alert


Originator: MHRA Drug Alerts

From: Alison Bunce - Medicines and Healthcare Products Regulatory Agency

Issue date: 03-Jun-2019 11:00:05

This alert has been issued to:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health

  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Chief Executive
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive

Action category: Class 4: For information

Title: DRUG ALERT CLASS 4, FOR INFORMATION, BAXTER HEALTHCARE LIMITED, POTASSIUM CHLORIDE 0.15%W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION - BP 1000ML; POTASSIUM CHLORIDE 0.3% W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION 1000ML; POTASSIUM CHLORIDE 0.15% W/V AND GLUCOSE 10% W/V SOLUTION FOR INFUSION 500ML.

Broadcast content:
Baxter Healthcare Limited has informed us that the front panel of a number of infusion bags for some batches the above products was found to be missing the red text which highlights the presence of potassium chloride in the product formulation. 


Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website 
https://www.gov.uk/drug-device-alerts
 


Alert reference: EL(19)A/13

Attachments:
Cascade to:
  • #HospitalPharmacy#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency